# Regulation (EU) 2019/6 of the European Parliament and of the Council of 11 December 2018 on veterinary medicinal products and repealing Directive 2001/82/EC (Text with EEA relevance), Division 5

Extent: E+W+S+N.I.

Whenever a product forms part of a vaccination scheme recommended by the applicant, the priming or booster effect or the contribution of the veterinary immunological product to the efficacy of the scheme as a whole shall be demonstrated.

---
Source: https://www.legislation.gov.uk/eur/2019/6/annex/II/title/II/chapter/II/division/A/division/5 (the official version)
Page: https://openlegislation.uk/eu-regulation-2019-6/annex-II/title-II/chapter-II/division-A/division-5
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.

